Market Intelligence Resources
-
Overall Hospital Quality Star Rating On Hospital Compare Methodology Report (v3.0)
Market Intelligence Resource | January 19, 2018 -
FDA Approved Labeling For Invega Sustenna, Updated December 20, 2017, To Include Comparative Outcomes
Market Intelligence Resource | January 19, 2018 -
Some Massachusetts Group Homes For Children In Foster Care Did Not Always Comply With State Health & Safety Requirements (A-01-16-02500)
Market Intelligence Resource | January 19, 2018 -
Official Audit Report: Massachusetts Department Of Children & Families For The period January 1, 2014 Through December 31, 2015
Market Intelligence Resource | January 19, 2018 -
The Nebraska Foster Care Review Office Annual Report, 2017
Market Intelligence Resource | January 19, 2018 -
Overall Hospital Quality Star Rating On Hospital Compare: December 2017 Updates & Specifications Report
Market Intelligence Resource | January 19, 2018 -
CMS Center For Clinical Standards & Quality/Survey & Certification Group Memorandum S&C:18-01-NH: Revised Policies Regarding The Immediate Imposition Of Federal Remedies
Market Intelligence Resource | January 19, 2018 -
North Dakota DHS Free Through Recovery Program Guidance
Market Intelligence Resource | January 19, 2018 -
U.S. Court Of Appeals For The Ninth Circuit: Opinion In Wilson v. Lynch
Market Intelligence Resource | January 19, 2018 -
Kentucky HEALTH Overview Presentation
Market Intelligence Resource | January 19, 2018 -
Kentucky HEALTH Medicaid 1115 Demonstration Fact Sheet
Market Intelligence Resource | January 19, 2018 -
Centers For Medicare & Medicaid Services Demonstration Approval For Kentucky HEALTH Medicaid Waiver
Market Intelligence Resource | January 19, 2018 -
Prescription Opioids: Medicare Should Expand Oversight Efforts To Reduce The Risk Of Harm – Highlights
Market Intelligence Resource | January 19, 2018 -
Prescription Opioids: Medicare Should Expand Oversight Efforts To Reduce The Risk Of Harm
Market Intelligence Resource | January 19, 2018 -
Medicare Part B: Medicare Represented At Least Half Of The Market For 22 Of The 84 Most Expensive Drugs In 2015 – Highlights
Market Intelligence Resource | January 19, 2018 -
Medicare Part B: Medicare Represented At Least Half Of The Market For 22 Of The 84 Most Expensive Drugs In 2015
Market Intelligence Resource | January 19, 2018 -
Maine Child Development Services Part B 619 Transition Committee Recommendations To The Department Of Education
Market Intelligence Resource | January 12, 2018 -
Additional FAQs On Sharing Information Related To Treatment For Mental Health Or Substance Use Disorder—Including Opioid Abuse
Market Intelligence Resource | January 12, 2018 -
Early Release Of Selected Estimates Based On Data From The National Health Interview Survey, January–June 2017: Personal Care Needs
Market Intelligence Resource | January 12, 2018 -
‘AHCCCS Works’ Arizona Medicaid 1115 Waiver Amendment Request
Market Intelligence Resource | January 12, 2018 -
Rhode Island Office Of The Child Advocate: Report Of The Child Fatality Review Panel, A Review Of Two Child Fatalities & Four Near Fatalities
Market Intelligence Resource | January 12, 2018 -
HIPAA Privacy Rule & Sharing Information Related To Mental Health
Market Intelligence Resource | January 12, 2018 -
Minnesota Medical Cannabis Autism Brief
Market Intelligence Resource | January 12, 2018 -
Michigan DHHS White Paper On The Section 298 Pilots To Integrate Behavioral & Physical Health
Market Intelligence Resource | January 12, 2018 -
Petitions To Add Qualifying Medical Conditions To The Medical Cannabis Program: A Report To The Minnesota Commissioner Of Health
Market Intelligence Resource | January 12, 2018
